NCT00232622View on ClinicalTrials.gov

A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Prosthetic Valve Thrombosis

Interventions

DRUG

Streptokinase

Accelerated infusion of streptokinase

DRUG

Streptokinase

Standard dose streptokinase

All Listed Sponsors

lead

All India Institute of Medical Sciences

OTHER

NCT00232622 - A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots | Biotech Hunter | Biotech Hunter